Cargando…

The Value of Contrast-Enhanced Magnetic Resonance Imaging Enhancement in the Differential Diagnosis of Hepatocellular Carcinoma and Combined Hepatocellular Cholangiocarinoma

BACKGROUND: The distinction between combined hepatocellular-cholangiocarcinoma (cHCC-CC) and hepatocellular carcinoma (HCC) before the operation has an important clinical significance for optimizing the treatment plan and predicting the prognosis of patients. Magnetic resonance imaging (MRI) has bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Lun, Zhang, ChenCai, Yu, Xian, Zhang, Ling, Feng, YaYuan, Wu, YuXian, Xia, JinJu, Chen, Xue, Zhang, RuiPing, Zhang, Juan, Jia, Ningyang, Zhang, SiSi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499763/ https://www.ncbi.nlm.nih.gov/pubmed/36157231 http://dx.doi.org/10.1155/2022/4691172

Ejemplares similares

Preoperative differentiation of hepatocellular carcinoma with peripheral rim-like enhancement from intrahepatic mass-forming cholangiocarcinoma on contrast-enhanced MRI
por: Zhang, Sisi, et al.
Publicado: (2022)

A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm)
por: Zhang, Sisi, et al.
Publicado: (2022)

The value of CT findings combined with inflammatory indicators for preoperative differentiation of benign and malignant gallbladder polypoid lesions
por: Zhang, Juan, et al.
Publicado: (2023)

Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading
por: Chen, Wen, et al.
Publicado: (2021)

Hepatobiliary Phase Features of Preoperative Gadobenate-Enhanced MR can Predict Early Recurrence of Hepatocellular Carcinoma in Patients Who Underwent Anatomical Hepatectomy
por: Liu, Wanmin, et al.
Publicado: (2022)

Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Yang, Jie, et al.
Publicado: (2020)

Preoperative Prediction of Microvascular Invasion in Patients With Hepatocellular Carcinoma Based on Radiomics Nomogram Using Contrast-Enhanced Ultrasound
por: Zhang, Di, et al.
Publicado: (2021)

Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics
por: Zhang, Yang, et al.
Publicado: (2023)

Association between contrast enhancement on contrast-enhanced CT and lenvatinib effectiveness in hepatocellular carcinoma
por: Okamura, Shusuke, et al.
Publicado: (2022)

Radiomics Based on Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma from Hepatocellular Carcinoma: A Multi-Center Study
por: Guo, Le, et al.
Publicado: (2023)

Novel model combining contrast-enhanced ultrasound with serology predicts hepatocellular carcinoma recurrence after hepatectomy
por: Tu, Hai-Bin, et al.
Publicado: (2021)

Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016
por: Zhang, Juanjuan, et al.
Publicado: (2017)

Bi-specific T1 positive-contrast-enhanced magnetic resonance imaging molecular probe for hepatocellular carcinoma in an orthotopic mouse model
por: Ma, Xiao-Hong, et al.
Publicado: (2022)

Clinical value of contrast-enhanced ultrasound in early diagnosis of small hepatocellular carcinoma (≤ 2 cm)
por: Mei, Qi, et al.
Publicado: (2022)

Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma: strengths and shortcomings
por: Lee, Sung Won, et al.
Publicado: (2023)

Preoperative radiomics model using gadobenate dimeglumine-enhanced magnetic resonance imaging for predicting β-catenin mutation in patients with hepatocellular carcinoma: A retrospective study
por: Zeng, Fengxia, et al.
Publicado: (2022)

Contrast-enhanced ultrasound imaging features and clinical characteristics of combined hepatocellular cholangiocarcinoma: comparison with hepatocellular carcinoma and cholangiocarcinoma
por: Zhang, Hai-Chun, et al.
Publicado: (2020)

Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma
por: Deng, Peng-Zhan, et al.
Publicado: (2022)

Assessing diagnostic value of contrast-enhanced ultrasound and contrast-enhanced computed tomography in detecting small hepatocellular carcinoma: A meta-analysis
por: Huang, Jiasheng, et al.
Publicado: (2017)

Correlation of radiomic features on dynamic contrast-enhanced magnetic resonance with microvessel density in hepatocellular carcinoma based on different models
por: Liang, Hongwei, et al.
Publicado: (2021)

Contrast-enhanced CT findings-based model to predict MVI in patients with hepatocellular carcinoma
por: Yue, Qi, et al.
Publicado: (2022)

Simple Clinical Metrics Enhance AFP to Effectively Identify Cirrhotic Patients With Complicating Hepatocellular Carcinoma at Various AFP Levels
por: Zhang, Xi, et al.
Publicado: (2020)

Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma
por: Chen, Chuang, et al.
Publicado: (2017)

Diagnostic value of liver contrast-enhanced ultrasound in early hepatocellular carcinoma: a systematic review and meta-analysis
por: Zhang, Zhilan, et al.
Publicado: (2023)

Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity
por: Wu, Jian-Wei, et al.
Publicado: (2018)

Contrast-enhanced ultrasound features of hepatocellular carcinoma in dogs
por: Banzato, Tommaso, et al.
Publicado: (2020)

Preoperative Radiomics Analysis of Contrast-Enhanced CT for Microvascular Invasion and Prognosis Stratification in Hepatocellular Carcinoma
por: Xu, Tingfeng, et al.
Publicado: (2022)

Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography
por: Zhu, Xiao-Dong, et al.
Publicado: (2011)

Contrast-Enhanced Imaging Features and Clinicopathological Investigation of Steatohepatitic Hepatocellular Carcinoma
por: Chen, Kailing, et al.
Publicado: (2023)

Imaging Features of Hepatocellular Carcinoma in the Non-Cirrhotic Liver with Sonazoid-Enhanced Contrast-Enhanced Ultrasound
por: Chen, Sheng, et al.
Publicado: (2022)

Contrast Agents for Hepatocellular Carcinoma Imaging: Value and Progression
por: Zhang, Ying, et al.
Publicado: (2022)

High correlation between microbubble contrast-enhanced ultrasound, magnetic resonance and histopathology in the evaluation of hepatocellular carcinoma
por: de Queiroz, Marcos Roberto Gomes, et al.
Publicado: (2013)

Preoperative prediction of cholangiocyte phenotype hepatocellular carcinoma on contrast-enhanced MRI and the prognostic implication after hepatectomy
por: Chen, Yidi, et al.
Publicado: (2023)

Usefulness of contrast-enhanced ultrasonography in the diagnosis of ruptured hepatocellular carcinoma
por: Shiozawa, Kazue, et al.
Publicado: (2013)

Radiomics Analysis Based on Contrast-Enhanced MRI for Prediction of Therapeutic Response to Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Zhao, Ying, et al.
Publicado: (2021)

Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction
por: Tu, Haibin, et al.
Publicado: (2023)

Contrast enhanced ultrasound combined with serology predicts hepatocellular carcinoma recurrence: a retrospective observation cohort study
por: Tu, Haibin, et al.
Publicado: (2023)

Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma
por: Zhao, Ying, et al.
Publicado: (2023)

Study on the Diagnostic Value of Contrast-Enhanced Ultrasound and Magnetic Resonance Imaging in Prostate Cancer
por: Pang, Xinnian, et al.
Publicado: (2022)

Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity
por: Yan, Yu-Chuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oe3vpj9sdpq4oe83nkis1fk54a